ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: DeVita wins $150,000 Pezcoller Prize; BreastPac To “Storm” Capitol On Bastille Day For More $$

July 8, 1988

The Cancer Letter Stands By Story

October 30, 1998

IOM Finds Insufficient Evidence to Link Polio Vaccine, Cancer

October 25, 2002

Senate Votes To Invalidate Task Force Guideline

December 4, 2009

Prevention, Centers To Gain, some $$ In President’s Budget

February 8, 1991

New Therapies For Genitourinary Cancers In Clinical Testing Presented At ASCO

July 25, 2003